The WHO has recently published a draft guideline, including two annexes, on Good Clinical Practice (GCP) for clinical trials involving medicinal products.
Comments on these documents may be submitted until 6 September 2026
Access the documens here:
- Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products – Main Principles (QAS/26.995)
- Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products – Annex 1 (QAS/26.995)
- Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products – Annex 2 (QAS/26.995)